Breadcrumb Navigation:

National Home > Chapters > Upper Midwest > Programs and services > Research and clinical trials > Clinical trials

Clinical trials

Below is a bookmarked list of the current clinical trials in the Upper Midwest Chapter territory sorted by area. If you're interested in any of the trials, please contact the person listed for more information. Click here for more information on National MS Society clinical trials.

Bismarck, ND | Des Moines, IA | Fargo, ND | Mayo Clinic Rochester | Minneapolis U of M | Minneapolis

Bismarck, ND

Name of clinic

MediciGlobal

Name of study

Study of Oral Teriflunomide (HMR1726)

Name of doctor

 --

Purpose of study

Recruiting People with Relapsing Forms of MS Worldwide. For further information, and to find out if this study is enrolling subjects at a site near you, please visit http://tower3.msstudies.com or call toll-free 1-866-565-0245.

Contact

1-866-565-0245

to top

  

Des Moines, IA

Name of clinic

Mercy Ruan Neurology Clinic

Name of study

Currently enrolling: AB Science, OPERA

Name of doctor

Varies

Purpose of study

Varies with each study

Contact

Val, 515-358-0002

to top

   

Minneapolis U of M

Name of clinic

University of Minnesota MS Center

Name of trial

MRI Research Study

Name of doctor

Dr. Adam Carpenter

Purpose of study

The U of M is conducting a study to evaluate novel MRI sequences and compare them to conventional MRI's in MS patients and healthy controls. You may be eligible for this study if you have a diagnosis of MS or are a healthy control, are age 18 to 65, weigh under 250 pounds and can tolerate an MRI without sedation.

Contact

Clinical Neuroscience Research Unit at U of M, 612-626-5153

to top

  

Minneapolis U of M

Name of clinic

University of Minnesota MS Center

Name of trial

MEG

Name of doctor

Dr. Adam Carpenter

Purpose of study

The University of Minnesota is conducting a study to better understand brain functions in patients with CIS or any form of MS. This is not a treatment study. You may be eligible for this study if you have a diagnosis of CIS or MS, are aged 18 to 75, and would be willing to undergo a brain scan.

Contact

Clinical Neuroscience Research Unit at U of M, 612-626-5153

to top

 

Minneapolis U of M

Name of clinic

University of Minnesota MS Center

Name of trial

ACCLAIM

Name of doctor

Dr. Adam Carpenter

Purpose of study

The University of Minnesota is conducting a study to determine whether an investigational treatment is effective in preventing relapses in MS. You may be eligible if you have a diagnosis of relapsing-remitting MS, are aged 18 to 65, have had at least one relapse in the past year for which you sought medical attention or have had one or more gadolinium-enhanced MRI lesions in the past year.

Contact

Clinical Neuroscience Research Unit at U of M, 612-624-7745

to top

 

 

Minneapolis Clinic of Neurology

Name of clinic

Minneapolis Clinic of Neurology

Name of trial

Roche

Name of doctor

Dr. Gary Birnbaum

Purpose of study

A randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of Ocrelizumab in comparison to Interferon Beta-1a (Rebif) in patients with relapsing-remiting multiple sclerosis.

Contact

Nicole Goese, CCRP, 763-402-472

to top

Mayo Clinic

Name of clinic

Mayo Clinic

Name of trial

Aspirin Fatigue

Name of doctor

Dr. B Mark Keegan

Purpose of study

To study aspirin treatment for multiple sclerosis fatigue. You may be eligible if you are ambulatory without an aide, have had fatigue over eight weeks and are aged 18 to 65.

Contact

Darcy Rauchwarter, R.N., 507-284-9360

to top

 

Mayo Clinic

Name of clinic

Metro Urology

Name of trial

DIGNITY2

Name of doctor

 

Purpose of study

Study to assess an investigational dosage of approved medication to control urinary incontinence. You may be eligible if you are 18 years or older, stable MS for 3 months, urinary leakage for 3 months, have used at least one overactive bladder medication and are not using clean-intermittent self-catheterization. Click here for more information.

Contact

Cindy Holtz, 651-999-7033

to top

Didn't find what you're looking for? Call us at 800-582-5296, email us at contactus@nmss.org or click here to view an index of this website by topic.